Literature DB >> 27029759

[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing--Annual report 2014].

Alessandro Proclemer1, Massimo Zecchin2, Antonio D'Onofrio3, Giovanni Luca Botto4, Domenico Facchin, Luca Rebellato1, Marco Ghidina1, Giulia Bianco1, Emanuela Bernardelli1, Elsa Pucher1, Dario Gregori5.   

Abstract

BACKGROUND: The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) Registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2014 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.
METHODS: The Registry collects prospectively national PM and ICD implantation activity on the basis of European cards.
RESULTS: PM Registry: data about 24 680 PM implantations were collected (19 480 first implant and 5200 replacements). The number of collaborating centers was 208. Median age of treated patients was 81 years (75 quartile I; 86 quartile III). ECG indications included atrioventricular conduction disorders in 45.3% of first PM implants, sick sinus syndrome in 23.1%, atrial fibrillation plus bradycardia in 11.7%, other in 19.9%. Among atrioventricular conduction defects, third-degree atrioventricular block was the most common type (22.7% of first implants). Use of single-chamber PMs was reported in 26.9% of first implants, of dual-chamber PMs in 63.6%, of PMs with cardiac resynchronization therapy (CRT) in 1.7%, and of single lead atrial-synchronized ventricular stimulation (VDD/R PMs) in 7.8%. ICD Registry: data about 17 116 ICD implantations were collected (11 274 first implants and 5842 replacements). The number of collaborating centers was 424. Median age of treated patients was 71 years (62 quartile I; 77 quartile III). Primary prevention indication was reported in 72.3% of first implants, secondary prevention in 27.7% (cardiac arrest in 10.1%). A single-chamber ICD was used in 32.2% of first implants, dual-chamber in 37.1% and biventricular in 30.7%.
CONCLUSIONS: The PM and ICD Registry appears fundamental for monitoring PM and ICD utilization on a large national scale with rigorous examination of demographics and clinical indications. The PM Registry showed stable electrocardiographic and symptom indications, with an important prevalence of dual-chamber pacing. The use of CRT-PM regards a very limited number of patients. The ICD Registry documented a large use of prophylactic and biventricular ICD, reflecting a favorable adherence to trials and guidelines in clinical practice.

Entities:  

Mesh:

Year:  2016        PMID: 27029759     DOI: 10.1714/2174.23494

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  3 in total

Review 1.  [ICD in elderly patients].

Authors:  Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-03

2.  The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?

Authors:  Giovanni Luca Botto; Giovanni B Forleo; Alessandro Capucci; Francesco Solimene; Antonello Vado; Giovanni Bertero; Pietro Palmisano; Ennio Pisanò; Antonio Rapacciuolo; Tommaso Infusino; Alessandro Vicentini; Miguel Viscusi; Paola Ferrari; Antonello Talarico; Giovanni Russo; Giuseppe Boriani; Luigi Padeletti; Mariolina Lovecchio; Sergio Valsecchi; Antonio D'Onofrio
Journal:  Europace       Date:  2017-11-01       Impact factor: 5.214

3.  Early experience with permanent pacemaker implantation at a tertiary hospital in Nigeria.

Authors:  Uvie Ufuoma Onakpoya; Olugbenga Olalekan Ojo; Oghenevware Joel Eyekpegha; Abayomi Emmanuel Oguns; Anthony Olubunmi Akintomide
Journal:  Pan Afr Med J       Date:  2020-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.